Possible pharmacological treatment, such as melatonin, orexin, circadian molecules, as well as non-pharmacological treatments like light therapy, feeding behavior modification, exercise and other lifestyle interventions, may be attractive candidates for treating T2DM and AD from the circadian perspective. The gene discussed is HCRT; the disease is type 2 diabetes mellitus.